694 related articles for article (PubMed ID: 20702695)
21. Mdm2 mediates FMRP- and Gp1 mGluR-dependent protein translation and neural network activity.
Liu DC; Seimetz J; Lee KY; Kalsotra A; Chung HJ; Lu H; Tsai NP
Hum Mol Genet; 2017 Oct; 26(20):3895-3908. PubMed ID: 29016848
[TBL] [Abstract][Full Text] [Related]
22. BDNF in fragile X syndrome.
Castrén ML; Castrén E
Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
[TBL] [Abstract][Full Text] [Related]
23. Fragile X Mental Retardation Protein (FMRP) controls diacylglycerol kinase activity in neurons.
Tabet R; Moutin E; Becker JA; Heintz D; Fouillen L; Flatter E; Krężel W; Alunni V; Koebel P; Dembélé D; Tassone F; Bardoni B; Mandel JL; Vitale N; Muller D; Le Merrer J; Moine H
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3619-28. PubMed ID: 27233938
[TBL] [Abstract][Full Text] [Related]
24. Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse.
Ronesi JA; Huber KM
Sci Signal; 2008 Feb; 1(5):pe6. PubMed ID: 18272470
[TBL] [Abstract][Full Text] [Related]
25. Aberrant RNA translation in fragile X syndrome: From FMRP mechanisms to emerging therapeutic strategies.
Banerjee A; Ifrim MF; Valdez AN; Raj N; Bassell GJ
Brain Res; 2018 Aug; 1693(Pt A):24-36. PubMed ID: 29653083
[TBL] [Abstract][Full Text] [Related]
26. Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome.
Osterweil EK; Krueger DD; Reinhold K; Bear MF
J Neurosci; 2010 Nov; 30(46):15616-27. PubMed ID: 21084617
[TBL] [Abstract][Full Text] [Related]
27. Toward fulfilling the promise of molecular medicine in fragile X syndrome.
Krueger DD; Bear MF
Annu Rev Med; 2011; 62():411-29. PubMed ID: 21090964
[TBL] [Abstract][Full Text] [Related]
28. Fragile X mental retardation protein regulates protein expression and mRNA translation of the potassium channel Kv4.2.
Gross C; Yao X; Pong DL; Jeromin A; Bassell GJ
J Neurosci; 2011 Apr; 31(15):5693-8. PubMed ID: 21490210
[TBL] [Abstract][Full Text] [Related]
29. Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development.
Pop AS; Gomez-Mancilla B; Neri G; Willemsen R; Gasparini F
Psychopharmacology (Berl); 2014 Mar; 231(6):1217-26. PubMed ID: 24232444
[TBL] [Abstract][Full Text] [Related]
30. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
[TBL] [Abstract][Full Text] [Related]
31. Selective role of the catalytic PI3K subunit p110β in impaired higher order cognition in fragile X syndrome.
Gross C; Raj N; Molinaro G; Allen AG; Whyte AJ; Gibson JR; Huber KM; Gourley SL; Bassell GJ
Cell Rep; 2015 May; 11(5):681-8. PubMed ID: 25921527
[TBL] [Abstract][Full Text] [Related]
32. Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models.
Zhang J; Hou L; Klann E; Nelson DL
J Neurophysiol; 2009 May; 101(5):2572-80. PubMed ID: 19244359
[TBL] [Abstract][Full Text] [Related]
33. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.
Bassell GJ; Warren ST
Neuron; 2008 Oct; 60(2):201-14. PubMed ID: 18957214
[TBL] [Abstract][Full Text] [Related]
34. A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome.
Dictenberg JB; Swanger SA; Antar LN; Singer RH; Bassell GJ
Dev Cell; 2008 Jun; 14(6):926-39. PubMed ID: 18539120
[TBL] [Abstract][Full Text] [Related]
35. Kinase pathway inhibition restores PSD95 induction in neurons lacking fragile X mental retardation protein.
Yang Y; Geng Y; Jiang D; Ning L; Kim HJ; Jeon NL; Lau A; Chen L; Lin MZ
Proc Natl Acad Sci U S A; 2019 Jun; 116(24):12007-12012. PubMed ID: 31118285
[TBL] [Abstract][Full Text] [Related]
36. Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome.
Liu ZH; Huang T; Smith CB
Neurobiol Dis; 2012 Mar; 45(3):1145-52. PubMed ID: 22227453
[TBL] [Abstract][Full Text] [Related]
37. Altered mRNA transport, docking, and protein translation in neurons lacking fragile X mental retardation protein.
Kao DI; Aldridge GM; Weiler IJ; Greenough WT
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15601-6. PubMed ID: 20713728
[TBL] [Abstract][Full Text] [Related]
38. Synaptic vesicle dynamic changes in a model of fragile X.
Broek JAC; Lin Z; de Gruiter HM; van 't Spijker H; Haasdijk ED; Cox D; Ozcan S; van Cappellen GWA; Houtsmuller AB; Willemsen R; de Zeeuw CI; Bahn S
Mol Autism; 2016; 7():17. PubMed ID: 26933487
[TBL] [Abstract][Full Text] [Related]
39. Modulation of dendritic spines and synaptic function by Rac1: a possible link to Fragile X syndrome pathology.
Bongmba OY; Martinez LA; Elhardt ME; Butler K; Tejada-Simon MV
Brain Res; 2011 Jul; 1399():79-95. PubMed ID: 21645877
[TBL] [Abstract][Full Text] [Related]
40. S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade.
Narayanan U; Nalavadi V; Nakamoto M; Thomas G; Ceman S; Bassell GJ; Warren ST
J Biol Chem; 2008 Jul; 283(27):18478-82. PubMed ID: 18474609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
